Making decisions with real-world evidence and COVID-19
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial applications, data provenance and data quality serve as unwavering cornerstones for actionable insights. Yet, an unsettling trend has emerged in the form of "...
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
The coronavirus pandemic continues to be a disruptive force for patients and physicians across the...
Patient centricity is top of mind for life sciences companies today. In order to put the patient at...
Healthcare has the lowest digital ad spend among major industries today. Privacy protection laws...
Complex medical treatments like gene and immunotherapies have brought us into a new era of...
Connected devices are here to stay. The conveniences they offer can make it easy to forget just how...
By: John Chaisson, Data Privacy & Blockchain,HealthVerity Perhaps no other industry is as heavily...
HIPAA (Health Insurance Portability and Accountability Act) has long been the acronym synonymous...
4 part series [Part 3] ofMatching Accuracy Metrics |Catch up on Part 1 and Part 2, or read Part 4
4 part series [Part 2] ofMatching Accuracy MetricsContinue readingPart 1,Part 3, and Part 4By:...
Traditional data aggregators are not enough The pharmaceutical industry is hitting a wall. Data aggregators, once considered reliable partners, are now liabilities facing significant challenges, including cyber threats, data restrictions, and opaque ...